Why This Small Cap Biopharma Stock Belongs In Your Portfolio

Today, we take a look at a promising biopharma concern named Flexion Pharmaceuticals who recently garnered FDA approval

There is no art which one government sooner learns of another than that of draining money from the pockets of the people.” ― Adam Smith, The Wealth of Nations

Comments

Stories